Magnetic resonance imaging (MRI)-based volumetric measurements of medi
al temporal lobe (MTL) structures can discriminate between normal elde
rly control subjects and patients with Alzheimer's disease (AD) of mod
erate to advanced severity. In terms of clinical utility, however, a m
ore important issue concerns the ability of the technique to different
iate between normal elderly control subjects and AD patients with the
very mildest form of the disease. We performed MRI-based volumetric me
asurements of the hippocampus, parahippocampal gyrus, and amygdala in
126 cognitively normal elderly control subjects and 94 patients with p
robable AD. The diagnosis of BD was made according to NINDS/ADRDA crit
eria, and disease severity was categorized by Clinical Dementia Rating
(CDR) scores. Patients with CDR 0.5 were classified as very mild, CDR
1 as mild, and CDR 2 as moderate disease severity. Volumes of each st
ructure declined with increasing age in control subjects and did so in
parallel for men and women. The volume of each measured MTL structure
also declined with age in patients with AD. The volume of each MTL st
ructure was significantly smaller in AD patients than control subjects
(p < 0.001). Of the several MTL measures, the total hippocampal volum
etric measurements were best at discriminating control subjects from A
D patients. The mean hippocampal volumes for AD patients relative to c
ontrol subjects by severity of disease were as follows: very mild AD (
CDR 0.5) -1.75 SD below the control mean, mild AD (CDR 1) -1.99 SD, an
d moderate AD (CDR 2) -2.22 SD, Age- and gender-adjusted, normalized M
RI-based hippocampal volumetric measurements provide a sensitive marke
r of the MTL neuroanatomic degeneration in AD early in the disease pro
cess.